p16 Immunohistochemical Expression as a Surrogate Assessment of CDKN2A Alteration in Gliomas Leading to Prognostic Significances

SIMPLE SUMMARY: The 2021 WHO classification of central nervous system tumors is a histomolecular classification system that takes into account numerous molecular data in order to better stratify patient prognoses and treatments. CDKN2A homozygous deletion appears to be associated with poor prognosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Geyer, Lucas, Wolf, Thibaut, Chenard, Marie-Pierre, Cebula, Helene, Schott, Roland, Noel, Georges, Guerin, Eric, Pencreach, Erwan, Reita, Damien, Entz-Werlé, Natacha, Lhermitte, Benoît
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000516/
https://www.ncbi.nlm.nih.gov/pubmed/36900302
http://dx.doi.org/10.3390/cancers15051512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000516/
https://www.ncbi.nlm.nih.gov/pubmed/36900302
http://dx.doi.org/10.3390/cancers15051512

Ejemplares similares